TNF-α triggers hepatocyte apoptosis, necrosis, liver inflammation and regeneration, autoimmune hepatitis and HCC, making it a promising diagnostic biomarker and appealing therapeutic target for NAFLD-associated HCC (27). This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.